Equinox Group offers ways to characterize and track patients that prevalence-based models cannot address. We work with clients to determine the most appropriate market map or patient flow model for the marketing challenges they face.
|
Natural History Modeling
When new therapies could dramatically change the disease course and population size or when market segments are linked to each other through disease progression, as in oncology markets, Natural History Modeling can elucidate how changes in treatments at one point in the disease course may affect downstream opportunities. [learn more] |
Predictive Patient Flow Modeling
When markets are characterized by progressive diseases and multiple lines of therapy or when you need to understand complex diagnosis, treatment, and referral patterns, Predictive Patient Flow Modeling can quantify sources of business and identify specific marketing targets. [learn more] |
|
|
Patient-Based Simulation
When patient-level data are available for markets where many patient characteristics affect treatment choice or when complex treatment regimens must be modeled, Patient-Based Simulation can track and project from large quantities of detailed information about patients and treatment regimens. [learn more] |
||